{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T21:25:30Z","timestamp":1794000330940,"version":"4.8.0"},"reference-count":67,"publisher":"American Association for Cancer Research (AACR)","issue":"12","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2004,6,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>With the objective of identifying candidate tumor suppressor genes, we used fluorescence in situ hybridization to map leukemia-related deletions of the long arm of chromosome 6 (6q). Twenty of 24 deletions overlapped to define a 4.8-Mb region of minimal deletion between markers D6S1510 and D6S1692 within chromosome 6 band q16. Using reverse transcription-PCR, we found evidence of expression in hematopoietic cells for 3 of 15 genes in the region (GRIK2, C6orf111, and CCNC). Comparison between our own and published deletion data singled out GRIK2 as the gene most frequently affected by deletions of 6q in acute lymphocytic leukemia (ALL). Sequence analysis of GRIK2 in 14 ALL cases carrying heterozygous 6q deletions revealed a constitutional and paternally inherited C to G substitution in exon 6 encoding for an amino acid change in one patient. The substitution was absent among 232 normal alleles tested, leaving open the possibility that heterozygous carriers of such mutations may be susceptible to ALL. Although low in all normal hematopoietic tissues, quantitative reverse transcription-PCR showed higher baseline GRIK2 expression in thymus and T cells than other lineages. Among T-cell ALL patients, 6q deletion was associated with a statistically significant reduction in GRIK2 expression (P = 0.0001). By contrast, elevated GRIK2 expression was measured in the myelomonocytic line THP-1 and in one patient with common ALL. Finally, we detected significant levels of GRIK2 expression in prostate, kidney, trachea, and lung, raising the possibility that this gene may be protective against multiple tumor types.<\/jats:p>","DOI":"10.1158\/0008-5472.can-03-1871","type":"journal-article","created":{"date-parts":[[2005,9,20]],"date-time":"2005-09-20T22:39:18Z","timestamp":1127255958000},"page":"4089-4098","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["A Fluorescence <b>\n                     <i>in Situ<\/i>\n                  <\/b> Hybridization Map of 6q Deletions in Acute Lymphocytic Leukemia"],"prefix":"10.1158","volume":"64","author":[{"given":"Paul B.","family":"Sinclair","sequence":"first","affiliation":[{"name":"Haematology Department, Royal Free and University College School of Medicine, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amani","family":"Sorour","sequence":"additional","affiliation":[{"name":"Haematology Department, Royal Free and University College School of Medicine, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Martineau","sequence":"additional","affiliation":[{"name":"Haematology Department, Royal Free and University College School of Medicine, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine J.","family":"Harrison","sequence":"additional","affiliation":[{"name":"Haematology Department, Royal Free and University College School of Medicine, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayne A.","family":"Mitchell","sequence":"additional","affiliation":[{"name":"Haematology Department, Royal Free and University College School of Medicine, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"O\u2019Neill","sequence":"additional","affiliation":[{"name":"Haematology Department, Royal Free and University College School of Medicine, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Letizia","family":"Foroni","sequence":"additional","affiliation":[{"name":"Haematology Department, Royal Free and University College School of Medicine, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2004,6,17]]},"reference":[{"key":"2022061620102328000_B1","doi-asserted-by":"crossref","unstructured":"Lu YJ, Xiao S, Yan YS, Fu SB, Liu QZ, Li P Direct chromosome analysis of 50 primary breast carcinomas. Cancer Genet Cytogenet, 69:\u200891-9, \u20081993.","DOI":"10.1016\/0165-4608(93)90081-V"},{"key":"2022061620102328000_B2","unstructured":"Visakorpi T, Kallioniemi AH, Syvanen AC, et al Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization. Cancer Res, 55:\u2008342-7, \u20081995."},{"key":"2022061620102328000_B3","doi-asserted-by":"crossref","unstructured":"Thompson FH, Emerson J, Alberts D, et al Clonal chromosome abnormalities in 54 cases of ovarian carcinoma. Cancer Genet Cytogenet, 73:\u200833-45, \u20081994.","DOI":"10.1016\/0165-4608(94)90179-1"},{"key":"2022061620102328000_B4","doi-asserted-by":"crossref","unstructured":"Ozisik YY, Meloni AM, Altungoz O, et al Cytogenetic findings in 21 malignant melanomas. Cancer Genet Cytogenet, 77:\u200869-73, \u20081994.","DOI":"10.1016\/0165-4608(94)90152-X"},{"key":"2022061620102328000_B5","unstructured":"Mertens F, Johansson B, Hoglund M, Mitelman F Chromosomal imbalance maps of malignant solid tumors: a cytogenetic survey of 3185 neoplasms. Cancer Res, 57:\u20082765-80, \u20081997."},{"key":"2022061620102328000_B6","unstructured":"Mitelman F . Catalog of chromosome aberrations in cancer,   Wiley-Liss New York  \u20081994."},{"key":"2022061620102328000_B7","doi-asserted-by":"crossref","unstructured":"Miyakawa A, Ichimura K, Schmidt EE, Varmeh-Ziaie S, Collins VP Multiple deleted regions on the long arm of chromosome 6 in astrocytic tumours. Br J Cancer, 82:\u2008543-9, \u20082000.","DOI":"10.1054\/bjoc.1999.0961"},{"key":"2022061620102328000_B8","doi-asserted-by":"crossref","unstructured":"De Souza AT, Hankins GR, Washington MK, Orton TC, Jirtle RL M6P\/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity. Nat Genet, 11:\u2008447-9, \u20081995.","DOI":"10.1038\/ng1295-447"},{"key":"2022061620102328000_B9","unstructured":"Cooney KA, Wetzel JC, Consolino CM, Wojno KJ Identification and characterization of proximal 6q deletions in prostate cancer. Cancer Res, 56:\u20084150-3, \u20081996."},{"key":"2022061620102328000_B10","doi-asserted-by":"crossref","unstructured":"Orphanos V, McGown G, Hey Y, et al Allelic imbalance of chromosome 6q in ovarian tumours. Br J Cancer, 71:\u2008666-9, \u20081995.","DOI":"10.1038\/bjc.1995.132"},{"key":"2022061620102328000_B11","doi-asserted-by":"crossref","unstructured":"O\u2019Connell P, Pekkel V, Fuqua SA, Osborne CK, Clark GM, Allred DC Analysis of loss of heterozygosity in 399 premalignant breast lesions at 15 genetic loci. J. Natl Cancer Inst (Bethesda), 90:\u2008697-703, \u20081998.","DOI":"10.1093\/jnci\/90.9.697"},{"key":"2022061620102328000_B12","doi-asserted-by":"crossref","unstructured":"Sheng ZM, Marchetti A, Buttitta F, et al Multiple regions of chromosome 6q affected by loss of heterozygosity in primary human breast carcinomas. Br J Cancer, 73:\u2008144-7, \u20081996.","DOI":"10.1038\/bjc.1996.27"},{"key":"2022061620102328000_B13","doi-asserted-by":"crossref","unstructured":"Offit K, Chaganti RS Chromosomal aberrations in non-Hodgkin\u2019s lymphoma. Biologic and clinical correlations. Hematol Oncol Clin N Am, 5:\u2008853-69, \u20081991.","DOI":"10.1016\/S0889-8588(18)30389-7"},{"key":"2022061620102328000_B14","doi-asserted-by":"crossref","unstructured":"Raimondi SC Current status of cytogenetic research in childhood acute lymphoblastic leukemia. Blood, 81:\u20082237-51, \u20081993.","DOI":"10.1182\/blood.V81.9.2237.2237"},{"key":"2022061620102328000_B15","doi-asserted-by":"crossref","unstructured":"Hayashi Y, Raimondi SC, Look AT, et al Abnormalities of the long arm of chromosome 6 in childhood acute lymphoblastic leukemia. Blood, 76:\u20081626-30, \u20081990.","DOI":"10.1182\/blood.V76.8.1626.bloodjournal7681626"},{"key":"2022061620102328000_B16","unstructured":"Kamada N, Sakurai M, Miyamoto K, et al Chromosome abnormalities in adult T-cell leukemia\/lymphoma: a karyotype review committee report. Cancer Res, 52:\u20081481-93, \u20081992."},{"key":"2022061620102328000_B17","unstructured":"Glassman AB, Harper-Allen EA, Hayes KJ, Hopwood VL, Gutterman EE, Zagryn SP Chromosome 6 abnormalities associated with prolymphocytic acceleration in chronic lymphocytic leukemia. Ann Clin Lab Sci, 28:\u200824-9, \u20081998."},{"key":"2022061620102328000_B18","doi-asserted-by":"crossref","unstructured":"Wong KF, Chan JK, Kwong YL Identification of del(6)(q21q25) as a recurring chromosomal abnormality in putative NK cell lymphoma\/leukaemia. Br J Haematol, 98:\u2008922-6, \u20081997.","DOI":"10.1046\/j.1365-2141.1997.3223139.x"},{"key":"2022061620102328000_B19","doi-asserted-by":"crossref","unstructured":"Offit K, Parsa NZ, Gaidano G, et al 6q deletions define distinct clinico-pathologic subsets of non-Hodgkin\u2019s lymphoma. Blood, 82:\u20082157-62, \u20081993.","DOI":"10.1182\/blood.V82.7.2157.bloodjournal8272157"},{"key":"2022061620102328000_B20","doi-asserted-by":"crossref","unstructured":"Cytogenetic abnormalities in adult acute lymphoblastic leukemia: correlations with hematologic findings outcome. A Collaborative Study of the Group Francais de Cytogenetique Hematologique. Blood, 87:\u20083135-42, \u20081996.","DOI":"10.1182\/blood.V87.8.3135.bloodjournal8783135"},{"key":"2022061620102328000_B21","doi-asserted-by":"crossref","unstructured":"Secker-Walker LM, Prentice HG, Durrant J, Richards S, Hall E, Harrison G Cytogenetics adds independent prognostic information in adults with acute lymphoblastic leukaemia on MRC trial UKALL XA. MRC Adult Leukaemia Working Party. Br J Haematol, 96:\u2008601-10, \u20081997.","DOI":"10.1046\/j.1365-2141.1997.d01-2053.x"},{"key":"2022061620102328000_B22","doi-asserted-by":"crossref","unstructured":"Walters R, Kantarjian HM, Keating MJ, et al The importance of cytogenetic studies in adult acute lymphocytic leukemia. Am J Med, 89:\u2008579-87, \u20081990.","DOI":"10.1016\/0002-9343(90)90175-D"},{"key":"2022061620102328000_B23","doi-asserted-by":"crossref","unstructured":"Mancini M, Vegna ML, Castoldi GL, et al Partial deletions of the long arm of chromosome 6: biologic and clinical implications in adult lymphocytic leukemia. Leukemia (Baltimore), 16:\u20082055-61, \u20082002.","DOI":"10.1038\/sj.leu.2402640"},{"key":"2022061620102328000_B24","doi-asserted-by":"crossref","unstructured":"Heerema NA, Sather HN, Sensel MG, et al Clinical significance of deletions of chromosome arm 6q in childhood acute lymphoblastic leukemia: a report from the Children\u2019s Cancer Group. Leuk Lymphoma, 36:\u2008467-78, \u20082000.","DOI":"10.3109\/10428190009148394"},{"key":"2022061620102328000_B25","doi-asserted-by":"crossref","unstructured":"Menasce LP, Orphanos V, Santibanez-Koref M, Boyle JM, Harrison CJ Common region of deletion on the long arm of chromosome 6 in non-Hodgkin\u2019s lymphoma and acute lymphoblastic leukaemia. Genes Chromosomes Cancer, 10:\u2008286-8, \u20081994.","DOI":"10.1002\/gcc.2870100411"},{"key":"2022061620102328000_B26","doi-asserted-by":"crossref","unstructured":"Sherratt T, Morelli C, Boyle JM, Harrison CJ Analysis of chromosome 6 deletions in lymphoid malignancies provides evidence for a region of minimal deletion within a 2-megabase segment of 6q21. Chromosome Res, 5:\u2008118-24, \u20081997.","DOI":"10.1023\/A:1018418224660"},{"key":"2022061620102328000_B27","unstructured":"Jackson A, Carrara P, Duke V, et al Deletion of 6q16\u2013q21 in human lymphoid malignancies: a mapping and deletion analysis. Cancer Res, 60:\u20082775-9, \u20082000."},{"key":"2022061620102328000_B28","doi-asserted-by":"crossref","unstructured":"Zhang Y, Matthiesen P, Harder S, et al A 3-cM commonly deleted region in 6q21 in leukemias and lymphomas delineated by fluorescence in situ hybridization. Genes Chromosomes Cancer, 27:\u200852-8, \u20082000.","DOI":"10.1002\/(SICI)1098-2264(200001)27:1<52::AID-GCC7>3.0.CO;2-X"},{"key":"2022061620102328000_B29","doi-asserted-by":"crossref","unstructured":"Gerard B, Cave H, Guidal C, Dastugue N, Vilmer E, Grandchamp B Delineation of a 6-cM commonly deleted region in childhood acute lymphoblastic leukemia on the 6q chromosomal arm. Leukemia (Baltimore), 11:\u2008228-32, \u20081997.","DOI":"10.1038\/sj.leu.2400566"},{"key":"2022061620102328000_B30","unstructured":"Takeuchi S, Koike M, Seriu T, et al Frequent loss of heterozygosity on the long arm of chromosome 6: identification of two distinct regions of deletion in childhood acute lymphoblastic leukemia. Cancer Res, 58:\u20082618-23, \u20081998."},{"key":"2022061620102328000_B31","doi-asserted-by":"crossref","unstructured":"Merup M, Moreno TC, Heyman M, et al 6q deletions in acute lymphoblastic leukemia and non-Hodgkin\u2019s lymphomas. Blood, 91:\u20083397-400, \u20081998.","DOI":"10.1182\/blood.V91.9.3397"},{"key":"2022061620102328000_B32","doi-asserted-by":"crossref","unstructured":"Hatta Y, Yamada Y, Tomonaga M, Miyoshi I, Said JW, Koeffler HP Detailed deletion mapping of the long arm of chromosome 6 in adult T-cell leukemia. Blood, 93:\u2008613-6, \u20081999.","DOI":"10.1182\/blood.V93.2.613.402k13_613_616"},{"key":"2022061620102328000_B33","unstructured":"Mitelman F . An international system for human cytogenetic nomenclature,   Karger Basel, Switzerland  \u20081995."},{"key":"2022061620102328000_B34","doi-asserted-by":"crossref","unstructured":"Harrison CJ, Martineau M, Secker-Walker LM The Leukaemia Research Fund\/United Kingdom Cancer Cytogenetics Group Karyotype Database in acute lymphoblastic leukaemia: a valuable resource for patient management. Br J Haematol, 113:\u20083-10, \u20082001.","DOI":"10.1046\/j.1365-2141.2001.02643.x"},{"key":"2022061620102328000_B35","unstructured":"Mungall AJ, Palmer SA, Sims SK, et al The DNA sequence and analysis of human chromosome 6. Nature (Lond.), 425:\u2008805-11, \u20082003."},{"key":"2022061620102328000_B36","doi-asserted-by":"crossref","unstructured":"Sinclair PB, Green AR, Grace C, Nacheva EP Improved sensitivity of BCR-ABL detection: a triple-probe three-color fluorescence in situ hybridization system. Blood, 90:\u20081395-402, \u20081997.","DOI":"10.1182\/blood.V90.4.1395.1395_1395_1402"},{"key":"2022061620102328000_B37","doi-asserted-by":"crossref","unstructured":"Mortuza FY, Moreira IM, Papaioannou M, et al Immunoglobulin heavy-chain gene rearrangement in adult acute lymphoblastic leukemia reveals preferential usage of J(H)-proximal variable gene segments. Blood, 97:\u20082716-26, \u20082001.","DOI":"10.1182\/blood.V97.9.2716"},{"key":"2022061620102328000_B38","unstructured":"Foroni L, Sorour AF, Sinclair PB, Duke VD Loss of heterozygosity (LOH) and microsatellite instability (MSI) of chromosome 6q16-21 identifies a prognostically poor group of childhood and adult T-cell precursor acute lymphoblastic leukaemia (ALL) patients. Blood, 102:\u2008606\u20082003."},{"key":"2022061620102328000_B39","doi-asserted-by":"crossref","unstructured":"Barbon A, Vallini I, Barlati S Genomic organization of the human GRIK2 gene and evidence for multiple splicing variants. Gene (Amst.), 274:\u2008187-97, \u20082001.","DOI":"10.1016\/S0378-1119(01)00611-4"},{"key":"2022061620102328000_B40","unstructured":"Devaraj PE, Foroni L, Janossy G, Hoffbrand AV, Secker-Walker LM Expression of the E2A-PBX1 fusion transcripts in t(1;19)(q23;p13) and der(19)t(1;19) at diagnosis and in remission of acute lymphoblastic leukemia with different B lineage immunophenotypes. Leukemia (Baltimore), 9:\u2008821-5, \u20081995."},{"key":"2022061620102328000_B41","doi-asserted-by":"crossref","unstructured":"Michaud JL, Rosenquist T, May NR, Fan CM Development of neuroendocrine lineages requires the bHLH-PAS transcription factor SIM1. Genes Dev, 12:\u20083264-75, \u20081998.","DOI":"10.1101\/gad.12.20.3264"},{"key":"2022061620102328000_B42","doi-asserted-by":"crossref","unstructured":"Hill J, Duckworth M, Murdock P, et al Molecular cloning and functional characterization of MCH2, a novel human MCH receptor. J Biol Chem, 276:\u200820125-9, \u20082001.","DOI":"10.1074\/jbc.M102068200"},{"key":"2022061620102328000_B43","doi-asserted-by":"crossref","unstructured":"Savinainen A, Garcia EP, Dorow D, Marshall J, Liu YF Kainate receptor activation induces mixed lineage kinase-mediated cellular signaling cascades via post-synaptic density protein 95. J Biol Chem, 276:\u200811382-6, \u20082001.","DOI":"10.1074\/jbc.M100190200"},{"key":"2022061620102328000_B44","doi-asserted-by":"crossref","unstructured":"Akoulitchev S, Chuikov S, Reinberg D TFIIH is negatively regulated by cdk8-containing mediator complexes. Nature (Lond.), 407:\u2008102-6, \u20082000.","DOI":"10.1038\/35024111"},{"key":"2022061620102328000_B45","unstructured":"Liu ZJ, Tanaka Y, Mine S, et al Functional cooperation of cyclin C and c-Myc in mediating homotypic cell adhesion via very late antigen-4 activation and vascular cell adhesion molecule-1 induction. Blood, 92:\u20084700-11, \u20081998."},{"key":"2022061620102328000_B46","doi-asserted-by":"crossref","unstructured":"Meldrum BS Glutamate as a neurotransmitter in the brain: review of physiology and pathology. J Nutr, 130:\u20081007S-15S, \u20082000.","DOI":"10.1093\/jn\/130.4.1007S"},{"key":"2022061620102328000_B47","doi-asserted-by":"crossref","unstructured":"Ikonomidou C, Bosch F, Miksa M, et al Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain. Science (Wash. DC), 283:\u200870-4, \u20081999.","DOI":"10.1126\/science.283.5398.70"},{"key":"2022061620102328000_B48","doi-asserted-by":"crossref","unstructured":"Behar TN, Scott CA, Greene CL, et al Glutamate acting at NMDA receptors stimulates embryonic cortical neuronal migration. J Neurosci, 19:\u20084449-61, \u20081999.","DOI":"10.1523\/JNEUROSCI.19-11-04449.1999"},{"key":"2022061620102328000_B49","doi-asserted-by":"crossref","unstructured":"Komuro H, Rakic P Modulation of neuronal migration by NMDA receptors. Science (Wash. DC), 260:\u200895-7, \u20081993.","DOI":"10.1126\/science.8096653"},{"key":"2022061620102328000_B50","doi-asserted-by":"crossref","unstructured":"Cavalheiro EA, Olney JW Glutamate antagonists: deadly liaisons with cancer. Proc Natl Acad Sci USA, 98:\u20085947-8, \u20082001.","DOI":"10.1073\/pnas.121179198"},{"key":"2022061620102328000_B51","doi-asserted-by":"crossref","unstructured":"Li H, Lahti JM, Valentine M, et al Molecular cloning and chromosomal localization of the human cyclin C (CCNC) and cyclin E (CCNE) genes: deletion of the CCNC gene in human tumors. Genomics, 32:\u2008253-9, \u20081996.","DOI":"10.1006\/geno.1996.0112"},{"key":"2022061620102328000_B52","doi-asserted-by":"crossref","unstructured":"Mori H, Colman SM, Xiao Z, et al Chromosome translocations and covert leukemic clones are generated during normal fetal development. Proc Natl Acad Sci USA, 99:\u20088242-7, \u20082002.","DOI":"10.1073\/pnas.112218799"},{"key":"2022061620102328000_B53","doi-asserted-by":"crossref","unstructured":"Mulle C, Sailer A, Perez-Otano I, et al Altered synaptic physiology and reduced susceptibility to kainate-induced seizures in GluR6-deficient mice. Nature (Lond.), 392:\u2008601-5, \u20081998.","DOI":"10.1038\/33408"},{"key":"2022061620102328000_B54","doi-asserted-by":"crossref","unstructured":"Levite M Nervous immunity: neurotransmitters, extracellular K+ and T-cell function. Trends Immunol, 22:\u20082-5, \u20082001.","DOI":"10.1016\/S1471-4906(00)01799-3"},{"key":"2022061620102328000_B55","doi-asserted-by":"crossref","unstructured":"Kostanyan IA, Merkulova MI, Navolotskaya EV, Nurieva RI Study of interaction between l-glutamate and human blood lymphocytes. Immunol Lett, 58:\u2008177-80, \u20081997.","DOI":"10.1016\/S0165-2478(97)00086-2"},{"key":"2022061620102328000_B56","doi-asserted-by":"crossref","unstructured":"Eck HP, Frey H, Droge W Elevated plasma glutamate concentrations in HIV-1-infected patients may contribute to loss of macrophage and lymphocyte functions. Int Immunol, 1:\u2008367-72, \u20081989.","DOI":"10.1093\/intimm\/1.4.367"},{"key":"2022061620102328000_B57","doi-asserted-by":"crossref","unstructured":"Droge W, Eck HP, Betzler M, Schlag P, Drings P, Ebert W Plasma glutamate concentration and lymphocyte activity. J Cancer Res Clin Oncol, 114:\u2008124-8, \u20081988.","DOI":"10.1007\/BF00417824"},{"key":"2022061620102328000_B58","doi-asserted-by":"crossref","unstructured":"Eck HP, Betzler M, Schlag P, Droge W Partial recovery of lymphocyte activity in patients with colorectal carcinoma after curative surgical treatment and return of plasma glutamate concentrations to normal levels. J Cancer Res Clin Oncol, 116:\u2008648-50, \u20081990.","DOI":"10.1007\/BF01637088"},{"key":"2022061620102328000_B59","doi-asserted-by":"crossref","unstructured":"Eck HP, Drings P, Droge W Plasma glutamate levels, lymphocyte reactivity and death rate in patients with bronchial carcinoma. J Cancer Res Clin Oncol, 115:\u2008571-4, \u20081989.","DOI":"10.1007\/BF00391360"},{"key":"2022061620102328000_B60","doi-asserted-by":"crossref","unstructured":"Ganor Y, Besser M, Ben-Zakay N, Unger T, Levite M Human T cells express a functional ionotropic glutamate receptor GluR3, and glutamate by itself triggers integrin-mediated adhesion to laminin and fibronectin and chemotactic migration. J Immunol, 170:\u20084362-72, \u20082003.","DOI":"10.4049\/jimmunol.170.8.4362"},{"key":"2022061620102328000_B61","doi-asserted-by":"crossref","unstructured":"Pollock PM, Cohen-Solal K, Sood R, et al Melanoma mouse model implicates metabotropic glutamate signaling in melanocytic neoplasia. Nat Genet, 34:\u2008108-12, \u20082003.","DOI":"10.1038\/ng1148"},{"key":"2022061620102328000_B62","doi-asserted-by":"crossref","unstructured":"Arai Y, Takashima S, Becker LE Down-regulation of glutamate receptor subunit 2(3) in subependymal giant-cell tumor. Pediatr Neurol, 23:\u200837-41, \u20082000.","DOI":"10.1016\/S0887-8994(00)00143-0"},{"key":"2022061620102328000_B63","doi-asserted-by":"crossref","unstructured":"Markert JM, Fuller CM, Gillespie GY, et al Differential gene expression profiling in human brain tumors. Physiol Genomics, 5:\u200821-33, \u20082001.","DOI":"10.1152\/physiolgenomics.2001.5.1.21"},{"key":"2022061620102328000_B64","doi-asserted-by":"crossref","unstructured":"Rzeski W, Turski L, Ikonomidou C Glutamate antagonists limit tumor growth. Proc Natl Acad Sci USA, 98:\u20086372-7, \u20082001.","DOI":"10.1073\/pnas.091113598"},{"key":"2022061620102328000_B65","doi-asserted-by":"crossref","unstructured":"Takano T, Lin JH, Arcuino G, Gao Q, Yang J, Nedergaard M Glutamate release promotes growth of malignant gliomas. Nat Med, 7:\u20081010-5, \u20082001.","DOI":"10.1038\/nm0901-1010"},{"key":"2022061620102328000_B66","doi-asserted-by":"crossref","unstructured":"Klegeris A, Walker DG, McGeer PL Regulation of glutamate in cultures of human monocytic THP-1 and astrocytoma U-373 MG cells. J Neuroimmunol, 78:\u2008152-61, \u20081997.","DOI":"10.1016\/S0165-5728(97)00094-5"},{"key":"2022061620102328000_B67","doi-asserted-by":"crossref","unstructured":"Gill SS, Pulido OM, Mueller RW, McGuire PF Molecular and immunochemical characterization of the ionotropic glutamate receptors in the rat heart. Brain Res Bull, 46:\u2008429-34, \u20081998.","DOI":"10.1016\/S0361-9230(98)00012-4"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/64\/12\/4089\/2515864\/zch01204004089.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/64\/12\/4089\/2515864\/zch01204004089.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T20:28:33Z","timestamp":1655411313000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/64\/12\/4089\/511427\/A-Fluorescence-in-Situ-Hybridization-Map-of-6q"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,6,15]]},"references-count":67,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2004,6,17]]},"published-print":{"date-parts":[[2004,6,15]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-03-1871","relation":{},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,6,15]]}}}